
-
Trump evokes Russia sanctions after largest assault on Ukraine
-
Afghans both hopeful, disappointed after Russia's Taliban recognition
-
Scotland survive stirring Maori All Blacks comeback for 29-26 win
-
Search continues after Pakistan building collapse kills 14
-
Texas flood toll rises to 24 as rescuers search for missing children
-
Brazil starlet Estevao 'ready' for Chelsea move: Palmeiras coach
-
Texas flash flood death toll rises to 24
-
Chelsea edge Palmeiras to reach Club World Cup semis
-
Eight OPEC+ alliance members move toward output hike at meeting
-
Prayers for the Dalai Lama in the heart of Mongolian Buddhism
-
Rivals ready to rock as fans flood in for Tour de France opener
-
Djokovic banks on 'home' advantage against Davis Cup teammate at Wimbledon
-
Ozzy Osbourne set for swansong at Black Sabbath hometown gig
-
Family and football unite to bid Diogo Jota farewell
-
Bombers and a 'beautiful bill' -- Trump celebrates US Independence Day
-
Mbappe 'better' and ready for Real Madrid against Dortmund at Club World Cup
-
BRICS nations to denounce Trump tariffs
-
Ghim maintains one-shot lead at PGA's John Deere Classic
-
Bayern Club World Cup clash with PSG a 'perfect storm': Kompany
-
Al Hilal showed Saudi league not just about money, says Koulibaly
-
PSG 'dead' unless they keep improving: Luis Enrique
-
MLB Cubs smash team-record eight homers to crush Cardinals
-
Mark Snow, composer of 'X Files' theme, dead at 78
-
Trump signs 'big, beautiful' bill on US Independence Day
-
US sprinter Richardson seeks to kickstart season after February injury
-
West Indies and Australia 2nd Test finely poised
-
Bosnia ends warrant for Bosnian Serb leader after questioning
-
Germany see off Poland in Women's Euro 2025 opener
-
Alcaraz into Wimbledon last 16 as Sabalenka outlasts Raducanu
-
Fluminense beat Al Hilal 2-1 to reach Club World Cup semis
-
At least 13 dead, 20 missing in Texas flash flood
-
Sabalenka outguns Raducanu to reach Wimbledon last 16
-
BRICS nations to gather without Xi, Putin
-
Heavy snow hits Turkey's northeast as wildfires rage
-
Brazil's Gabigol wins appeal in anti-doping case
-
Salah 'frightened' to return to Liverpool as fans mourn tragic Jota
-
Siraj 'loving the challenge' of leading India's attack against England
-
France says 'major issues' remain despite brandy price accord with China
-
'Always hiding': Haitian laborers fear Dominican deportation push
-
Rugby World Cup-winning Springboks coach White leaves Bulls
-
UK rock legends Oasis kick off 'historic' comeback tour
-
Alcaraz in Wimbledon last 16 as seeds tumble again
-
Kipyegon, Duplantis, Thompson highlight Eugene Diamond League
-
Australia wrest back control against West Indies
-
Erratic Alcaraz battles into Wimbledon fourth round
-
Search on for survivors of Pakistan building collapse
-
Blink and you'll miss it: Shelton wraps up match in 71 seconds
-
India on top despite Smith and Brook's hundred heroics in 2nd Test
-
Sweden beat rivals Norway at Women's Euro 2025
-
India on top despite Smith and Brook's hundred heroics in third Test

Biotech Community Curetopia Raises $1.77M to Advance Rare Disease Cures with Blockchain
Curetopia, a Biotech DAO, leverages decentralized science to accelerate rare disease research
ZUG, SWITZERLAND / ACCESS Newswire / March 20, 2025 / In a groundbreaking achievement, Curetopia, the first Biotech Decentralized Autonomous Organization (DAO) built natively on the Solana blockchain, raised $1.77 million last week to scale up drug repurposing for inherited metabolic diseases through the Bio Protocol Launchpad. This milestone is driving cutting-edge research aimed at developing the first treatment for AARS2 Deficiency, a potentially fatal rare genetic disease with no approved therapies currently on the market.
Curetopia's innovative approach empowers patients and researchers to crowdfund medical breakthroughs, emphasizing community involvement and a shared stake in the resulting advancements. Over 1,000 individual contributors participated in this $1.77 million raise, highlighting the power of community-driven science. Participants in Curetopia's decentralized clinical trials become active stakeholders in the therapies they help to develop.
A key outcome of this effort is the identification of two drug repurposing candidates for AARS2 Deficiency, uncovered by a fully de-risked, high-throughput, yeast-powered screening process. Curetopia is filing a provisional patent for this discovery, working with two pioneer AARS2 families on launching parallel N-of-1 studies, and plans to reinvest any future proceeds into further research initiatives.
Dr. Ethan Perlstein, founder and CEO of Curetopia, stated:
"The success of Curetopia's auction in the face of brutal market conditions speaks to the fact that rare disease communities and crypto communities are natural allies. We've already demonstrated with the inaugural AARS2 program that we can deliver results on a timeline and with capital efficiency that is unheard of in TradBio. Now it's time to cook."
Curetopia is part of the growing Decentralized Science (DeSci) movement, which has collectively raised over $15 million for research in the past three months. This influx of funding is timely, as traditional sources like the NIH and NSF face ongoing budget pressures.
Moving forward, Curetopia will develop an AI-driven, decentralized clinical trial model to address thousands of rare diseases-each representing a $150 million market opportunity based on historical sales of Priority Review Vouchers. By focusing on drug repurposing, the organization seeks to expedite regulatory processes and deliver life-changing treatments to patients more quickly.
About Curetopia
Curetopia is a non-profit association pioneering the world's first Biotech DAO dedicated to eradicating rare diseases through decentralized science launched via the Bio Protocol launchpad. With over 10,000 rare diseases affecting 1 in 10 people worldwide, Curetopia provides patient communities with innovative tools to fund research, drive innovation, and ensure promising therapies are not abandoned.
Bio Protocol is a new financial layer for early-stage biotech, accelerating the commercialization of breakthrough research. It enables global communities-patients, researchers, and crypto users-to fund and co-own biotech innovations from day one. Backed by Binance Labs, Northpond Ventures, and 1kx, Bio has facilitated over $50M in research funding worldwide.
PR Contact:
ZEX PR WIRE
[email protected]
SOURCE: Curetopia
View the original press release on ACCESS Newswire
Ch.Havering--AMWN